4D MOLECULAR THERAPEUTICS IN

Watch

Share

FDMT·35104E100·US·Common Stock·Healthcare - Biotechnology-13D/G

FDMT (4D MOLECULAR THERAPEUTICS IN) is held by 93 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($67.2M), BlackRock, Inc. ($60.5M), GOLDMAN SACHS GROUP INC ($56.6M). Net institutional sentiment: Mixed.

93

Holders

(8 Elite)

$447.3M

Total Value

66% (93)

Consensus

61 buying - 32 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)37

Insider (Form 4)70

Activist (13D/13G)55

Congressional (STOCK Act)74

Holder Quality

20

★★★★★

Elite

26

★★★★

Strong

28

★★★

Solid

66

★★

Below

11

★

Weak

Held by 93 funds

8 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 21, 2026 · Activists May 15, 2026 · Congress none

InsiderKDKirn DavidSell $663KAug 19, 2026

InsiderKDKirn DavidExercise 50K shAug 19, 2026

InsiderKDKirn DavidSell $426KAug 19, 2026

Checking access…

View all insider tradesView all activist filings

Top Holders

Top Holders (93)History

AllNewIncreasedHeldDecreasedExited

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
RA CAPITAL MANAGEMENT, L.P.	Unchanged	5M	$67.2M	0.6%	-8.03%	0
BlackRock, Inc.	Increased	4.5M(+9.7%)	$60.5M	0.0%	+152.63%	32
GOLDMAN SACHS GROUP INC	Increased	4.3M(+1.3%)	$56.6M	0.0%	+183.36%	30
STATE STREET CORP	Increased	2.9M(+7.5%)	$38.7M	0.0%	+20.31%	31
AGADAGE CAPITAL PARTNERS GP, L.L.C.	Increased	2.2M(+40.1%)	$29.9M	0.0%	+65.13%	38
VAVANGUARD CAPITAL MANAGEMENT LLC	Decreased	2.1M(-4.4%)	$27.9M	0.0%	+83.92%	0
GEODE CAPITAL MANAGEMENT, LLC	Increased	1.1M(+5.9%)	$15M	0.0%	-27.49%	30
BANK OF AMERICA CORP /DE/	Increased	1.1M(+15.0%)	$14.9M	0.0%	+154.70%	32
DIMENSIONAL FUND ADVISORS LP	Increased	730,857(+39.8%)	$9.7M	0.0%	+52.41%	37
DEUTSCHE BANK AG\	Increased	710,942(+0.4%)	$9.5M	0.0%	+64.65%	28
CITADEL ADVISORS LLC	Increased	687,597(+160.4%)	$9.1M	0.0%	+36.30%	45
RENAISSANCE TECHNOLOGIES LLC	Increased	614,573(+6.3%)	$8.2M	0.0%	+106.31%	29
VPVANGUARD PORTFOLIO MANAGEMENT LLC	Increased	579,903(+4.3%)	$7.7M	0.0%	+79.66%	29
NORTHERN TRUST CORP	Increased	562,929(+64.6%)	$7.5M	0.0%	-14.42%	40
Nuveen, LLC	Decreased	503,071(-10.4%)	$6.7M	0.0%	+106.07%	0
MORGAN STANLEY	Increased	503,020(+45.6%)	$6.7M	0.0%	-7.07%	37
RTW INVESTMENTS, LP	Unchanged	475,737	$6.3M	0.1%	+105.28%	0
Schonfeld Strategic Advisors LLC	Increased	407,470(+303.0%)	$5.4M	0.0%	+28.90%	44
JPMORGAN CHASE & CO	Decreased	402,137(-3.3%)	$5.2M	0.0%	+137.97%	0
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	Increased	339,275(+3.3%)	$4.5M	0.0%	-25.32%	28

Showing 1-20 of 104

Per page:

1 / 6

FDMT4D MOLECULAR THERAPEUTICS IN

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO

403 holders · $856.6B

UNHUNITEDHEALTH GROUP INC

403 holders · $286.8B

TMOTHERMO FISHER SCIENTIFIC INC

388 holders · $148B

JNJJOHNSON & JOHNSON

385 holders · $405.5B

DHRDANAHER CORP

384 holders · $95B

ISRGINTUITIVE SURGICAL INC

381 holders · $105.8B

MRKMERCK & CO. INC.

378 holders · $226B

BSXBOSTON SCIENTIFIC CORP

375 holders · $51.2B

ABBVABBVIE INC

373 holders · $296.3B

ABTABBOTT LABORATORIES

371 holders · $110.7B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer